Mario Bernardo-Filho

Mario Bernardo-Filho

Auto-generated profile, based on publicly available information

Mario Bernardo-Filho

Universidade do Estado do Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2005 in BMC Nuclear Medicine
Verified
Journal Article
Open access
PDF file
Samuel ValencaSamuel Valenca
Samuel Valenca
ELElaine Ac Lima
Elaine Ac Lima
GDGláucio F Dire
Gláucio F Dire
MBMário Bernardo-Filho
Mário Bernardo-Filho
LPLuis Cristóvão Porto
Luis Cristóvão Porto
The biological effects of cigarette smoke are not fully known. To improve our understanding of the action of various chemical agents, we investigated the biodistribution of sodium pertechnetate (Na99mTcO4) in mice exposed to cigarette smoke. Fifteen BALB/c male mice were exposed to the smoke of nine whole commercial cigarettes per day, 3 times/day, for up to 10 days to whole body exposure in a chamber. A control group of 5 BALB/c male mice was sham-smoked. One day later, the exposed and control groups of mice received (7.4 MBq/0.3 ml) of Na99mTcO4 before being killed at 30 min. Bones, brain, heart, intestine, kidney, liver, lungs, muscle, pancreas, spleen, stomach, testis and thyroid were weighed and these organs and blood radioactivity recorded with a gamma counter. The percentage per gram of tissue of injected dose (%ID/g) was determined for each organ. Cigarette smoke significantly decreased (p < 0.05) the %ID/g in red blood cells, bone, kidney, lung, spleen, stomach, testis and thyroid of the exposed mice. The toxic effects of cigarette smoke reduced the Na99mTcO4 biodistribution.

1 February 2004 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
SMS.R.F. Moreno
S.R.F. Moreno
RFR.S. Freitas
R.S. Freitas
ERE.K. Rocha
E.K. Rocha
GLG.L. Lima-Filho
G.L. Lima-Filho
MBM. Bernardo-Filho
M. Bernardo-Filho
Ginkgo biloba extract (EGb) is a phytotherapeutic agent used for the treatment of ischemic and neurological disorders. Because the action of this important extract is not fully known, assays using different biological systems need to be performed. Red blood cells (RBC) are labeled with technetium-99m (Tc-99m) and used in nuclear medicine. The labeling depends on a reducing agent, usually stannous chloride (SnCl2). We assessed the effect of different concentrations of EGb on the labeling of blood constituents with Tc-99m, as sodium pertechnetate (3.7 MBq), and on the mobility of a plasmid DNA treated with SnCl2 (1.2 microg/ml) at room temperature. Blood was incubated with EGb before the addition of SnCl2 and Tc-99m. Plasma (P) and RBC were separated and precipitated with trichloroacetic acid, and soluble (SF-P and SF-RBC) and insoluble (IF-P and IF-RBC) fractions were isolated. The plasmid was incubated with Egb, SnCl2 or EGb plus SnCl2 and agarose gel electrophoresis was performed. The gel was stained with ethidium bromide and the DNA bands were visualized by fluorescence in an ultraviolet transilluminator system. EGb decreased the labeling of RBC, IF-P and IF-RBC. The supercoiled form of the plasmid was modified by treatment with SnCl2 and protected by 40 mg/ml EGb. The effect of EGb on the tested systems may be due to its chelating action with the stannous ions and/or pertechnetate or to the capability to generate reactive oxygen species that could oxidize the stannous ion.

1 June 2005 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Open access
PDF file
JFJoelma F. de Oliveira Fernandes
Joelma F. de Oliveira Fernandes
LBLavínia de Carvalho Brito
Lavínia de Carvalho Brito
JFJacques N.G. Frydman
Jacques N.G. Frydman
SSSebastião D. Santos-Filho
Sebastião D. Santos-Filho
MBMario Bernardo-Filho
Mario Bernardo-Filho
Plants have been used for the human beings as food, as additives and/or as medicines. There are controversies about the biological effects of several natural products and, it is worthwhile to try to develop experimental assays to evaluate properties of extracts of plants. Pfaffia sp. is utilized in popular medicine and various properties have been attributed to its extract. Red blood cells (RBC) and plasma proteins are labeled with technetium-99m (Tc-99m) and this labeling procedure depends on a reducing agent and stannous ion is usually used. There are reports that drugs can alter the labeling of blood elements with Tc-99m. We have evaluated the influence of a Pfaffia sp. extract on the labeling of blood constituents with Tc-99m and on the morphology of RBC. Blood was incubated with an aqueous extract of Pfaffia sp., stannous chloride and Tc-99m. Samples were centrifuged and plasma and blood cells were separated and also precipitated with trichloroacetic acid. Soluble and insoluble fractions were separated. The results did not show alteration in the uptake of radioactivity and no modifications on the shape of the RBC in presence of Pfaffia sp. Once this labeling process depends on a reducing agent, probably, this extract has compounds with anti-oxidant properties as already described elsewhere, that could protect the stannous ions against the oxidation process. This fact would aid the labeling process of blood elements with Tc-99m.

22 January 2002 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
PDF file
MGMaria Luisa Gomes
Maria Luisa Gomes
ABAna Cristina de Souza Braga
Ana Cristina de Souza Braga
DMDeise Mara Machado de Mattos
Deise Mara Machado de Mattos
RFRosimeire de Souza Freitas
Rosimeire de Souza Freitas
MBMario Bernardo-Filho
Mario Bernardo-Filho
RBRoberto José A.C. Bezerra
Roberto José A.C. Bezerra

1 November 1998 in Toxicology Letters
Verified
Journal Article
Closed access
MAMaria Luciana B. Assis
Maria Luciana B. Assis
MCManuela R. Caceres
Manuela R. Caceres
JMJosé C.P. De Mattos
José C.P. De Mattos
ACAdriano Caldeira-De-Araújo
Adriano Caldeira-De-Araújo
MBMario Bernardo-Filho
Mario Bernardo-Filho

1 January 2002 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Open access
PDF file
SMSilvana Ramos Farias Moreno
Silvana Ramos Farias Moreno
GFGláucio Diré Feliciano
Gláucio Diré Feliciano
RFRosimeire Souza Freitas
Rosimeire Souza Freitas
MFMiguel Benito Farah
Miguel Benito Farah
GLGuilherme Lima Laurentino-Filho
Guilherme Lima Laurentino-Filho
MFMario Bernardo Filho
Mario Bernardo Filho
Ginkgo biloba is the phytoterapic most used in popular medicine in the treatment of cerebral senescence. Red blood cells (RBC) labeled with technetium-99m (Tc-99m) is used for several evaluations in nuclear medicine. This labeling depends on a reducing agent, usually the stannous ion. Any drug, which alters the labeling of the tracer, could be expected to modify the disposition of the radiopharmaceutical. We have evaluated the influence of the Ginkgo biloba extract on the labeling of RBC and plasma proteins with Tc-99m. Blood was withdrawn and incubated with Ginkgo biloba extract (0; 0.004; 0.04; 0.4; 4; 20 and 40 mg/ml). Stannous chloride (1.2 ml/ml) was added and, then, Tc-99m was added. Plasma (P) and blood cells (RBC) were isolated, also precipitated with trichloroacetic acid and soluble (SF) and insoluble fractions (IF) separated. The analysis of the results shows that there is a decrease in the radioactivity (from 97.7 ± 0.7 to 49.5 ± 3.9%) in RBC with the drug (4 mg/ml). In the labeling process of RBC with Tc-99m, the stannous and pertechnetate ions pass though the membrane, so, we suggest that the Ginkgo biloba effect can be explained by (i) an inhibition of the transport of these ions, (ii) damage in membrane, (iii) competition with the cited ions for the same binding sites, or (iv) possible generation of reactive oxygen species that could oxidize the stannous ion